Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04896905
Other study ID # Covid19_2020
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 1, 2020
Est. completion date May 18, 2021

Study information

Verified date May 2021
Source Klinik Valens
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The aim of the study is to gain insight into the rehabilitation process and predictive factors for the outcome after rehabilitation in three patient groups: 1. SARS-CoV-2-positive patients in the isolation ward 2. Post-Covid-19 patients 3. Control group; matched for gender, age and co-morbidity


Recruitment information / eligibility

Status Completed
Enrollment 101
Est. completion date May 18, 2021
Est. primary completion date February 28, 2021
Accepts healthy volunteers No
Gender All
Age group 40 Years to 100 Years
Eligibility Inclusion Criteria: - Patients assigned to rehab - Written informed consent Exclusion Criteria: - not able to fill in questionnaires in German

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Rehabilitation
Rehabilitative procedures in isolation ward

Locations

Country Name City State
Switzerland Rehabilitationszentrum Klinik Valens Valens SG

Sponsors (1)

Lead Sponsor Collaborator
Klinik Valens

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mobility Timed Up and Go-Test TUG (Seconds; less=better, normal <10 Sec.) Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)
Primary Functional Independence Measurement-Level (FIM) FIM at entry and discharge (min 18, max 126 points; higher level= better functioning; ) Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)
Primary Promis-10 (Promis= Patient reported outcome measurement information system) Level of patient self rated functioning in daily activities (higher level= better self related functioning) Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)
Primary Quality of life EQ5D- VAS (0-100; higher level = better quality of life) Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)
See also
  Status Clinical Trial Phase
Completed NCT05047692 - Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers Phase 1
Recruiting NCT04395768 - International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 Phase 2
Completed NCT04506268 - COVID-19 SAFE Enrollment N/A
Terminated NCT04555096 - A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 Phase 2
Completed NCT04508777 - COVID SAFE: COVID-19 Screening Assessment for Exposure
Completed NCT04961541 - Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine Phase 1/Phase 2
Active, not recruiting NCT04546737 - Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients N/A
Terminated NCT04581915 - PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 Phase 2/Phase 3
Terminated NCT04542993 - Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy Phase 2
Not yet recruiting NCT04543006 - Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19 N/A
Completed NCT04494646 - BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) Phase 2
Completed NCT04532294 - Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants Phase 1
Not yet recruiting NCT04527211 - Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel Phase 3
Completed NCT04537663 - Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults Phase 4
Completed NCT04387292 - Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04979858 - Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask N/A
Not yet recruiting NCT05038449 - Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19 N/A
Completed NCT04610502 - Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients Phase 2
Active, not recruiting NCT06042855 - ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) Phase 3